Oleptro

Oleptro is a pharmaceutical brand name of Trazodone hydrochloride, a triazolopyridine antidepressant drug, manufactured and marketed by Labopharm Europe Limited, Dublin, Ireland. It was approved by the FDA in February 2010 for use in the form of extended release tablets (Initial U.S. Approval: 1981)^[1]

References

1. ^ "Oleptro Full Prescribing Information in Drug Reference Encyclopedia". http://www.theodora.com/drugs/oleptro_trazodone_hydrochloride_extended-release_tablets_labopharm_europe_ltd.html. Retrieved 2010-02-16. .

External links

• Labopharm Europe Ltd. corporate website